title: Vitiligo therapy: where are we now?
abstract: Vitiligo is a disfiguring skin disease. Many insights into its pathogenesis have been identified in recent years; however, treatment remains a challenge. In this article, the various treatment options for the treatment of vitiligo are outlined and newer treatment options are discussed.
authors.affiliation: Ronald O Perelman Department of Dermatology, NYU School of Medicine, New York, New York, USA. mp.arroyo@stanfordalumni.org
authors.forename: Martha P
authors.initials: MP
authors.lastname: Arroyo
authors.forename: Louisa
authors.initials: L
authors.lastname: Tift
mesh_terms: D002648:Child; D006801:Humans; D008544:Melanocytes / Q000637:transplantation*; D008730:Methoxsalen / Q000008:administration & dosage; D011701:PUVA Therapy / Q000009:adverse effects*; D010789:Phototherapy; D012880:Skin Pigmentation; D016038:Skin Transplantation / Q000379:methods*; D014820:Vitiligo / Q000628:therapy*
chemical_list: D008730:Methoxsalen